Ang-1 Antibodies

Santa Cruz Biotechnology delivers a wide array of Ang-1 monoclonal antibodies for research focused on understanding Angiopoietin-1 (Ang-1) in various biological processes. Ang-1 monoclonal antibodies are validated for multiple techniques, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Angiopoietin-1 is a key regulator of angiogenesis and vascular stability, playing a crucial role in the development and maintenance of blood vessels. Through interaction with the Tie2 receptor, Angiopoietin-1 promotes endothelial cell survival and inhibits apoptosis, which is vital for proper vascular function. Research has shown that Angiopoietin-1 dysregulation is linked to various diseases, including cancer and cardiovascular disorders, highlighting its significance as a therapeutic target. Scientists worldwide utilize Ang-1 monoclonal antibodies to advance their understanding of angiogenesis mechanisms and potential therapeutic applications. Santa Cruz Biotechnology monoclonal antibodies enable researchers to make meaningful contributions to vascular biology research and therapeutic development.